Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseases
- PMID: 7616101
- DOI: 10.1002/jlb.58.1.1
Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseases
Abstract
Over the past 12 years, the poxvirus vector technology has provided scientists with valuable reagents to achieve high-level expression of proteins, to address questions of structure-function relationship of specific polypeptides, to investigate the immunobiology of specific pathogens, and to develop recombinant vaccine candidates. It is this last role that has drawn enthusiasm from the medical community because of the potential this technology has to provide novel approaches for addressing urgent needs in human and veterinary medicine. From one perspective, the safety issues surrounding the use of vaccinia-based vaccine candidates have been addressed with the development of the NYVAC and ALVAC vectors. Evaluation of these novel poxvirus vectors are in progress to determine their potential impact on cancer and infectious disease.
Similar articles
-
Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates.J Virol. 2015 Aug;89(16):8525-39. doi: 10.1128/JVI.01265-15. Epub 2015 Jun 3. J Virol. 2015. PMID: 26041302 Free PMC article.
-
Poxvirus-based vectors as vaccine candidates.Biologicals. 1995 Jun;23(2):159-64. doi: 10.1006/biol.1995.0026. Biologicals. 1995. PMID: 7546658 Review.
-
Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC.Dev Biol Stand. 1995;84:159-63. Dev Biol Stand. 1995. PMID: 7796949 Review.
-
Poxvirus-based vectors as vaccine candidates.Crit Rev Immunol. 1990;10(1):13-30. Crit Rev Immunol. 1990. PMID: 2407263 Review.
-
Vaccination against canine distemper virus infection in infant ferrets with and without maternal antibody protection, using recombinant attenuated poxvirus vaccines.J Virol. 2000 Jul;74(14):6358-67. doi: 10.1128/jvi.74.14.6358-6367.2000. J Virol. 2000. PMID: 10864646 Free PMC article.
Cited by
-
Recombinant vaccinia viruses. Design, generation, and isolation.Mol Biotechnol. 1999 Dec 15;13(3):223-45. doi: 10.1385/MB:13:3:223. Mol Biotechnol. 1999. PMID: 10934535
-
Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors.PLoS One. 2011 Feb 15;6(2):e16819. doi: 10.1371/journal.pone.0016819. PLoS One. 2011. PMID: 21347234 Free PMC article.
-
Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial.J Infect Dis. 2013 Jun 15;207(12):1888-97. doi: 10.1093/infdis/jit105. Epub 2013 Mar 12. J Infect Dis. 2013. PMID: 23482644 Free PMC article. Clinical Trial.
-
Role of cell signaling in poxvirus-mediated foreign gene expression in mammalian cells.Vaccine. 2009 May 14;27(22):2994-3006. doi: 10.1016/j.vaccine.2009.02.103. Epub 2009 Mar 10. Vaccine. 2009. PMID: 19428911 Free PMC article.
-
The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice.J Clin Invest. 2011 Jan;121(1):296-307. doi: 10.1172/JCI42056. Epub 2010 Dec 22. J Clin Invest. 2011. PMID: 21183789 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous